Cargando…
Myeloid Ezh2 Deficiency Limits Atherosclerosis Development
Macrophages define a key component of immune cells present in atherosclerotic lesions and are central regulators of the disease. Since epigenetic processes are important in controlling macrophage function, interfering with epigenetic pathways in macrophages might be a novel approach to combat athero...
Autores principales: | Neele, Annette E., Chen, Hung-Jen, Gijbels, Marion J. J., van der Velden, Saskia, Hoeksema, Marten A., Boshuizen, Marieke C. S., Van den Bossche, Jan, Tool, Anton T., Matlung, Hanke L., van den Berg, Timo K., Lutgens, Esther, de Winther, Menno P. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871783/ https://www.ncbi.nlm.nih.gov/pubmed/33574814 http://dx.doi.org/10.3389/fimmu.2020.594603 |
Ejemplares similares
-
Repressing the repressor: Ezh2 mediates macrophage activation
por: Neele, Annette E., et al.
Publicado: (2018) -
Targeting macrophage Histone deacetylase 3 stabilizes atherosclerotic lesions
por: Hoeksema, Marten A, et al.
Publicado: (2014) -
Targeting Histone Deacetylases in Myeloid Cells Inhibits Their Maturation and Inflammatory Function With Limited Effects on Atherosclerosis
por: Luque-Martin, Rosario, et al.
Publicado: (2019) -
Peritoneal macrophages have an impaired immune response in obesity which can be reversed by subsequent weight loss
por: Willemsen, Lisa, et al.
Publicado: (2019) -
Molecular Pathways Regulating Macrophage Polarization: Implications for Atherosclerosis
por: Hoeksema, Marten A., et al.
Publicado: (2012)